The Arizona Republic reports:
The treatment, called KEPTIDE, is a nasal spray that works by stopping the virus from attaching onto and entering cells. Studies done in mice, primate cells, and human lung cells have all been promising so far, the company said, showing 100% effectiveness with no negative side effects.
One hitch: The treatment won’t offer long-term protection. Its effects could work for only about a day and looks most promising for short-term uses.
And it won’t be able to offer protection to consumers anytime soon. The product still needs to be tested in humans and is a long way from being sold in stores or administered in health care settings. The company is currently waiting for FDA approval to start formal clinical trials for the treatment in humans.
Read the full article. Fascinating.